Literature DB >> 238774

Specific control of follicle stimulating hormone in the male: postulated site of action of inhibin.

F J Bramble, A L Houghton, S S Eccles, M A Murray, H S Jacobs.   

Abstract

Serum luteinizing and follicle stimulating hormone concentrations were related to gonadal function, as reflected by sperm count and serum testosterone concentrations, in a group of men studied over 10 years after surgical correction of bilateral cryptorchidism in childhood. The results indicated that while all degrees of gonadal function occurred in these patients, the main adverse effect of cryptorchidism was on spermatogenesis. In some of the patients with oligospermia and normal Leydig cell function there was an isolated increase of basal serum FSH concentrations, suggesting a specific impairment of the testicular production of 'inhibin'. Gonadotrophin releasing hormone (LHRH) tests in these patients were compared to those in patients with normal basal gonadotrophins and to those with elevated basal LH and FSH concentrations. A selective exaggeration of the FSH response to exogenous LHRH in the group of patients with a monotropic elevation of FSH concentrations suggests that 'inhibin' modulates the secretion of FSH by an action on the pituitary rather than by modifying endogenous LHRH production by the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 238774     DOI: 10.1111/j.1365-2265.1975.tb01552.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Editorial: Prospects in reversible contraception.

Authors: 
Journal:  Br Med J       Date:  1976-07-17

2.  Gonadal function in young adults after surgical treatment of cryptorchidism.

Authors:  E A Werder; R Illig; T Torresani; M Zachmann; P Baumann; F Ott; A Prader
Journal:  Br Med J       Date:  1976-12-04

3.  Reproductive and endocrine function in patients with Hodgkin's disease: effects of oophoropexy and irradiation.

Authors:  P R Thomas; D Winstanly; M J Peckham; D E Austin; M A Murray; H S Jacobs
Journal:  Br J Cancer       Date:  1976-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.